Clinical characteristics of paroxysmal kinesigenic choreoathetosis: Diagnosis, treatment and prognosis

Huicong Kang , Qi Hu , Xiaoyan Liu , Feng Xu , Lin Chen , Suiqiang Zhu

Current Medical Science ›› 2009, Vol. 29 ›› Issue (1) : 118 -121.

PDF
Current Medical Science ›› 2009, Vol. 29 ›› Issue (1) : 118 -121. DOI: 10.1007/s11596-009-0125-1
Article

Clinical characteristics of paroxysmal kinesigenic choreoathetosis: Diagnosis, treatment and prognosis

Author information +
History +
PDF

Abstract

The clinical characters, diagnosis and differential diagnosis of paroxysmal kinesigenic choreoathetosis (PKC), and efficacy of the anti-epileptic drugs (AEDs) were investigated. Thirty-one patients with PKC were collected, and the clinical characters and change of EEG were analyzed. The average age of the first attack was 16.8 years old and the pinnacle was 10 to 20 years old. There were definite causes for every attack and the sudden movement was the most common one (92%). Time for the whole attack was always less than 1 min. The attack presented with muscle tension disturbance (83.9%), movement like dancing (16.1%), abnormal movement of mouth and face and other symptoms (16.2%). The attack tended to be very frequent and 71% patients were beyond once per day. The EEG examination and image scan of primary PKC were normal in most patients. Low dosage of AEDs could control the attack of 50%–77.3% patients. It was concluded that PKC was a common disease of movement disorder. The therapy by AEDs was very effective. PKC should be differentiated from epilepsy and the relationship between PKC and epilepsy needs further research.

Keywords

paroxysmal kinesigenic choreoathetosis / clinical character / anti-epileptic therapy

Cite this article

Download citation ▾
Huicong Kang, Qi Hu, Xiaoyan Liu, Feng Xu, Lin Chen, Suiqiang Zhu. Clinical characteristics of paroxysmal kinesigenic choreoathetosis: Diagnosis, treatment and prognosis. Current Medical Science, 2009, 29(1): 118-121 DOI:10.1007/s11596-009-0125-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

BhatiaK.P.. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol, 2001, 21: 69-74

[2]

KatoN., SadamatsuM., KikuchiT., et al. . Paroxysmal kinesigenic choreoathetosis: from first discovery in 1892 to genetic linkage with benign familial infantile convulsions. Epilepsy Res, 2006, 70(Suppl1): S174-S184

[3]

SwobodaK.J., SoongB., McKennaC., et al. . Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology, 2000, 55: 224-230

[4]

Cuenca-LeonE., CormandB., ThomasonT., et al. . Paroxysmal kinesigenic dyskinesia and generalized seizures: Clinical and genetic analysis in a Spanish pedigree. Neuropediatrics, 2002, 33: 288-293

[5]

Fourcade G, Roubertie A, Doummar D, et al. Paroxysmal kinesigenic dyskinesia: A channelopathy? Study of 19 cases. Rev Neurol (Paris), 2008, Oct 13. [Epub ahead of print]

[6]

BrunoM.K., HallettM., Gwinn-HardyK., et al. . Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia new diagnostic criteria. J Neurology, 2004, 63(12): 2280-2287

[7]

VolonteM.A., PeraniD., LanziR., et al. . Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism. J Neurol Neurosurg Psychiatry, 2001, 71(5): 691-695

[8]

DemirE., Prud’hommeJ.F., TopçuM.. Infantile convulsions and paroxysmal choreoathetosis in a consanguineous family. Pediatr Neurol, 2004, 30(5): 349-353

[9]

TsaiJ.D., ChouI.C., TsaiF.J., et al. . Clinical manifestation and carbamazepine treatment of patients with paroxysmal kinesigenic choreoathetosis. Acta Paediatr Taiwan, 2005, 46(3): 138-142

[10]

IwasakiY., NakamuraT., HamadaK.. Late-onset of idiopathic paroxysmal kinesigenic choreoathetosis: a case report. Rinsho Shinkeigaku, 2004, 44(6): 365-368

[11]

YamashiroD., AiharaM., OnoC., et al. . Ictal SPECT and paired stimulation SEP recovery curve in a patient with paroxysmal kinesigenic choreoathetosis. No To Hattatsu, 2002, 34(6): 498-503

[12]

JooE.Y., HongS.B., TaeW.S., et al. . Perfusion abnormality of the caudate nucleus in patients with paroxysmal kinesigenic choreoathetosis. Eur J Nucl Med Mol Imaging, 2005, 32(10): 1205-1209

[13]

Iglesias-GomezS., Vadillo-OlmoF.J., Abella-CorralJ., et al. . Oxcarbazepine in the treatment of kinesigenic paroxysmal choreoathetosis, 2005, 41(5): 314-316

[14]

HuangY.G., ChenY.C., DuF., et al. . Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord, 2005, 20(1): 75-77

[15]

UberallM.A., WenzelD.. Effectiveness of lamotrigine in children with paroxysmal kinesigenic choreoathetosis. Dev Med Child Neurol, 2000, 42(10): 699-700

[16]

ChudnowR.S., MimbelaR.A., OwenD.B.. Gabapentin for familial paroxysmal dystonic choreoathetosis. Neurology, 1997, 49(5): 1441-1442

[17]

GuerriniR.. Idiopathic epilepsy and paroxysmal dyskinesia. Epilepsia, 2001, 42(Suppl3): 36-41

[18]

KammC., MayerP., SharmaM., et al. . New family with paroxysmal exercise-induced dystonia and epilepsy. Mov Disord, 2007, 22(6): 873-877

AI Summary AI Mindmap
PDF

82

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/